CRNDE was recently recognized as a key regulator in the metastasis and oxaliplatin resistance of CRC by working as a ceRNA for miR-136 and indirectly targeting E2F1 (Gao et al., 2017). This evidence concerns the gene E2F1 and colorectal carcinoma.